These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34047262)

  • 1. MicroRNAs: Key Regulators in Lung Cancer.
    El Founini Y; Chaoui I; Dehbi H; El Mzibri M; Abounader R; Guessous F
    Microrna; 2021; 10(2):109-122. PubMed ID: 34047262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-Based Biomarkers in Lung Cancer: Recent Advances and Potential Applications.
    Shanehbandi D; Asadi M; Seyedrezazadeh E; Zafari V; Shekari N; Akbari M; Rahbarnia L; Zarredar H
    Curr Mol Med; 2023 May; 23(7):648-667. PubMed ID: 35619321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.
    Otmani K; Rouas R; Lewalle P
    Front Immunol; 2022; 13():913951. PubMed ID: 36189271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Exosomal Noncoding RNAs in Lung Carcinogenesis.
    Sun T; Kalionis B; Lv G; Xia S; Gao W
    Biomed Res Int; 2015; 2015():125807. PubMed ID: 26583084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating miRNA detection in lung cancer.
    Zhao C; Lu F; Chen H; Zhao F; Zhu Z; Zhao X; Chen H
    Med Oncol; 2016 May; 33(5):41. PubMed ID: 27034265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of exosomal microRNAs in lung cancer biology and clinical applications.
    Hu C; Meiners S; Lukas C; Stathopoulos GT; Chen J
    Cell Prolif; 2020 Jun; 53(6):e12828. PubMed ID: 32391938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer.
    Tang S; Li S; Liu T; He Y; Hu H; Zhu Y; Tang S; Zhou H
    Cancer Lett; 2021 Apr; 502():71-83. PubMed ID: 33453304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of microRNAs in gynecological pathology.
    Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
    Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.
    Zhou Q; Huang SX; Zhang F; Li SJ; Liu C; Xi YY; Wang L; Wang X; He QQ; Sun CC; Li DJ
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M; Sharifi M
    J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer and microRNAs: therapeutic impact.
    Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E
    Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer.
    Wu J; Shen Z
    Cancer Med; 2020 Oct; 9(19):6909-6922. PubMed ID: 32779402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment.
    Zhao Q; Li P; Ma J; Yu X
    Recent Pat Anticancer Drug Discov; 2015; 10(2):182-200. PubMed ID: 25600282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients.
    Mjelle R; Dima SO; Bacalbasa N; Chawla K; Sorop A; Cucu D; Herlea V; Sætrom P; Popescu I
    BMC Cancer; 2019 Oct; 19(1):1007. PubMed ID: 31660891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines.
    Chiba M; Kimura M; Asari S
    Oncol Rep; 2012 Nov; 28(5):1551-8. PubMed ID: 22895844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
    Najafi A; Tavallaei M; Hosseini SM
    Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.